Cutting-Edge MSETM-TIL Platform for Enhanced Anti- Tumor Efficacy with Broader Clinical Applications
Time: 1:30 pm
day: Conference Day One - Track B - PM
Details:
- Introduction of the company and the backgroundUnique features of Biosyngen’s MSETM-TIL platform
- Efficient ex vivo expansion from tumor biopsy samples
- Efficient genetic modification system
- Pre-clinical data on anti-tumor efficacy of the MSETM-TIL system
